Clinical trial
Supersaturated Hydrogen-Rich Water for Outpatients With Persistent Excess Weight
Opening soon · Not applicable · 1 countries · Registry ID NCT07410065
What this study is about
The Supersaturated Hydrogen-Rich Water for Outpatients with Persistent Excess Weight (HOPE) study is a Phase III, multicenter, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of daily consumption of supersaturated hydrogen-rich water in adults with persistent excess body weight. The trial investigates whether sustained exposure to molecular hydrogen can favorably influence body composition and key metabolic outcomes compared with a placebo water lacking dissolved hydrogen. By enrolling outpatients across multiple centers and applying rigorous blinding and randomization procedures, HOPE aims to generate high-quality clinical evidence on the potential role of hydrogen-rich water as a non-pharmacological, adjunctive strategy for weight management and metabolic health.
Basic eligibility
Full registry criteria
Treatments and study arms
Hydrogen-rich water
Hydrogen-rich water (1.0 L per day)
Control
Hydrogen-free water (1.0 L per day)
Primary outcomes
Serum level of apolipoprotein B
Study locations
1 locations were listed when this page was built. The first 40 are shown.